Pathological response and survival with neoadjuvant therapy in melanoma: a pooled analysis from the International Neoadjuvant Melanoma Consortium (INMC) von Menzies, Alexander M., Amaria, Rodabe N., Rozeman, Elisa A., Huang, Alexander C., Tetzlaff, Michael T., van de Wiel, Bart A., Lo, Serigne, Tarhini, Ahmad A., Burton, Elizabeth M., Pennington, Thomas E., Saw, Robyn P. M., Xu, Xiaowei, Karakousis, Giorgos C., Ascierto, Paolo A., Spillane, Andrew J., van Akkooi, Alexander C. J., Davies, Michael A., Mitchell, Tara C., Tawbi, Hussein A., Scolyer, Richard A., Wargo, Jennifer A., Blank, Christian U., Long, Georgina V.

Volltext

Melanoma von Schadendorf, Dirk, van Akkooi, Alexander C J, Berking, Carola, Griewank, Klaus G, Gutzmer, Ralf, Hauschild, Axel, Stang, Andreas, Roesch, Alexander, Ugurel, Selma

Volltext

Reversal of pre-existing NGFR-driven tumor and immune therapy resistance von Boshuizen, Julia, Vredevoogd, David W., Krijgsman, Oscar, Ligtenberg, Maarten A., Blankenstein, Stephanie, de Bruijn, Beaunelle, Frederick, Dennie T., Kenski, Juliana C. N., Parren, Mara, Brüggemann, Marieke, Madu, Max F., Rozeman, Elisa A., Song, Ji-Ying, Horlings, Hugo M., Blank, Christian U., van Akkooi, Alexander C. J., Flaherty, Keith T., Boland, Genevieve M., Peeper, Daniel S.

Volltext

Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma von Eggermont, Alexander M.M, Blank, Christian U, Mandala, Mario, Long, Georgina V, Atkinson, Victoria, Dalle, Stéphane, Haydon, Andrew, Lichinitser, Mikhail, Khattak, Adnan, Carlino, Matteo S, Sandhu, Shahneen, Larkin, James, Puig, Susana, Ascierto, Paolo A, Rutkowski, Piotr, Schadendorf, Dirk, Koornstra, Rutger, Hernandez-Aya, Leonel, Maio, Michele, van den Eertwegh, Alfonsus J.M, Grob, Jean-Jacques, Gutzmer, Ralf, Jamal, Rahima, Lorigan, Paul, Ibrahim, Nageatte, Marreaud, Sandrine, van Akkooi, Alexander C.J, Suciu, Stefan, Robert, Caroline

Volltext

Neo-Adjuvant Therapy for Metastatic Melanoma von Kuijpers, Anke M J, van Akkooi, Alexander C J

Volltext

Neoadjuvant versus adjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma von Blank, Christian U., Rozeman, Elisa A., Fanchi, Lorenzo F., Sikorska, Karolina, van de Wiel, Bart, Kvistborg, Pia, Krijgsman, Oscar, van den Braber, Marlous, Philips, Daisy, Broeks, Annegien, van Thienen, Johannes V., Mallo, Henk A., Adriaansz, Sandra, ter Meulen, Sylvia, Pronk, Loes M., Grijpink-Ongering, Lindsay G., Bruining, Annemarie, Gittelman, Rachel M., Warren, Sarah, van Tinteren, Harm, Peeper, Daniel S., Haanen, John B. A. G., van Akkooi, Alexander C. J., Schumacher, Ton N.

Volltext

European consensus-based interdisciplinary guideline for melanoma. Part 2: Treatment - Update 2022 von Garbe, Claus, Amaral, Teresa, Peris, Ketty, Hauschild, Axel, Arenberger, Petr, Basset-Seguin, Nicole, Bastholt, Lars, Bataille, Veronique, del Marmol, Veronique, Dréno, Brigitte, Fargnoli, Maria C., Forsea, Ana-Maria, Grob, Jean-Jacques, Hoeller, Christoph, Kaufmann, Roland, Kelleners-Smeets, Nicole, Lallas, Aimilios, Lebbé, Celeste, Lytvynenko, Bodhan, Malvehy, Josep, Moreno-Ramirez, David, Nathan, Paul, Pellacani, Giovanni, Saiag, Philippe, Stratigos, Alexander J., Van Akkooi, Alexander C.J., Vieira, Ricardo, Zalaudek, Iris, Lorigan, Paul

Volltext

Relatlimab, an Immune Checkpoint Inhibitor that Blocks LAG-3, the Latest Drug to be Added to the Arsenal of Systemic Therapies for Melanoma: What Does a Surgical Oncologist Need to... von van Akkooi, Alexander C. J.

Volltext

European consensus-based interdisciplinary guideline for melanoma. Part 1: Diagnostics: Update 2022 von Garbe, Claus, Amaral, Teresa, Peris, Ketty, Hauschild, Axel, Arenberger, Petr, Basset-Seguin, Nicole, Bastholt, Lars, Bataille, Veronique, del Marmol, Veronique, Dréno, Brigitte, Fargnoli, Maria C., Forsea, Ana-Maria, Grob, Jean-Jacques, Höller, Christoph, Kaufmann, Roland, Kelleners-Smeets, Nicole, Lallas, Aimilios, Lebbé, Celeste, Lytvynenko, Bodhan, Malvehy, Josep, Moreno-Ramirez, David, Nathan, Paul, Pellacani, Giovanni, Saiag, Philippe, Stratigos, Alexander J., Van Akkooi, Alexander C.J., Vieira, Ricardo, Zalaudek, Iris, Lorigan, Paul

Volltext

Author Correction: Reversal of pre-existing NGFR-driven tumor and immune therapy resistance von Boshuizen, Julia, Vredevoogd, David W., Krijgsman, Oscar, Ligtenberg, Maarten A., Blankenstein, Stephanie, de Bruijn, Beaunelle, Frederick, Dennie T., Kenski, Juliana C. N., Parren, Mara, Brüggemann, Marieke, Madu, Max F., Rozeman, Elisa A., Song, Ji-Ying, Horlings, Hugo M., Blank, Christian U., van Akkooi, Alexander C. J., Flaherty, Keith T., Boland, Genevieve M., Peeper, Daniel S.

Volltext

Avelumab treatment for patients with metastatic Merkel cell carcinoma can be safely stopped after 1 year and a PET/CT–confirmed complete response von Zijlker, Lisanne P., Levy, Sonja, Wolters, Wendy, Thienen, Johannes V., Akkooi, Alexander C. J., Tesselaar, Margot E. T.

Volltext

Diagnosis and treatment of Merkel cell carcinoma: European consensus-based interdisciplinary guideline – Update 2022 von Gauci, Marie-Léa, Aristei, Cynthia, Becker, Jurgen C., Blom, Astrid, Bataille, Veronique, Dreno, Brigitte, Del Marmol, Veronique, Forsea, Ana M., Fargnoli, Maria C., Grob, Jean-Jacques, Gomes, Fabio, Hauschild, Axel, Hoeller, Christoph, Harwood, Catherine, Kelleners-Smeets, Nicole, Kaufmann, Roland, Lallas, Aimilios, Malvehy, Josep, Moreno-Ramirez, David, Peris, Ketty, Pellacani, Giovanni, Saiag, Philippe, Stratigos, Alexander J., Vieira, Ricardo, Zalaudek, Iris, van Akkooi, Alexander C.J., Lorigan, Paul, Garbe, Claus, Lebbé, Céleste

Volltext

High response rates for T‐VEC in early metastatic melanoma (stage IIIB/C‐IVM1a) von Franke, Viola, Berger, Danique M.S., Klop, W. Martin C., Hiel, Bernies, Wiel, Bart A., Meulen, Sylvia, Wouters, Michel W.J.M., Houdt, Winan J., Akkooi, Alexander C.J.

Volltext

The extent of surgery for stage III melanoma: how much is appropriate? von Franke, Viola, van Akkooi, Alexander C J

Volltext

Interferon-gamma signature as prognostic and predictive marker in macroscopic stage III melanoma von Versluis, Judith M, Blankenstein, Stephanie A, Dimitriadis, Petros, Wilmott, James S, Elens, Robert, Blokx, Willeke A M, van Houdt, Winan, Menzies, Alexander Maxwell, Schrage, Yvonne M, Wouters, Michel W J M, Sanders, Joyce, Broeks, Annegien, Scolyer, Richard A, Suijkerbuijk, Karijn P M, Long, Georgina V, Akkooi, Alexander C J van, Blank, Christian U

Volltext

The prognostic significance of sentinel node tumour burden in melanoma patients: An international, multicenter study of 1539 sentinel node-positive melanoma patients von van der Ploeg, Augustinus P.T, van Akkooi, Alexander C.J, Haydu, Lauren E, Scolyer, Richard A, Murali, Rajmohan, Verhoef, Cornelis, Thompson, John F, Eggermont, Alexander M.M

Volltext

Management of Localized Melanoma in the Anti-PD-1 Era von Novis, Elan, van Akkooi, Alexander C. J.

Volltext

Talimogene Laherparepvec in Combination with Immunotherapy, A Viable Option? von Zager, Jonathan S., van Akkooi, Alexander C. J.

Volltext

Development and validation of a novel model to predict recurrence-free survival and melanoma-specific survival after sentinel lymph node biopsy in patients with melanoma: an intern... von Stassen, Robert C, Maas, Carolien C H M, van der Veldt, Astrid A M, Lo, Serigne N, Saw, Robyn P M, Varey, Alexander H R, Scolyer, Richard A, Long, Georgina V, Thompson, John F, Rutkowski, Piotr, Keilholz, Ulrich, van Akkooi, Alexander C J, Verhoef, Cornelis, van Klaveren, David, Grünhagen, Dirk J

Volltext

Outcome after surgical treatment of dermatofibrosarcoma protuberans: Is clinical follow‐up always indicated? von Huis in ‘t Veld, Eva A., van Coevorden, Frits, Grünhagen, Dirk J., Smith, Myles J., van Akkooi, Alexander C. J., Wouters, Michel W. J. M., Hayes, Andrew J., Verhoef, Cornelis, Strauss, Dirk C., van Houdt, Winan J.

Volltext